NeoGenomics GC Alicia Olivo to step down; transition effective Sept 21, 2026

NEOGENOMICS INC

Announced Aug 11, 2026: EVP, General Counsel & Business Development Alicia Olivo will cease as GC effective Sept 21, 2026.
Olivo remains employee until Oct 2, 2026 for transition; separation payments per Section 5(b) of employment agreement.
No successor named; CFO Abhishek Jain signed filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.